Dewpoint Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 30, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Founders
- Anthony Hyman, Richard Young
- Company Description
- Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest diseases. Dewpoint is harnessing recent insights into biomolecular condensates elucidated by founders Anthony Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden and Richard Young of the Whitehead Institute with the goal to uncover treatments for the toughest diseases.
- Market
- Healthcare
- Location
- Cambridge, MA, USA
- Coinvestors
- 6 Dimensions Capital, Alexandria Real Estate Equities, EcoR1 Capital, Leaps by Bayer, Polaris Partners, Samsara BioCapital